still hot

News

or what all has happened in the last two years can be found on the following page.

The Ministry of Health unveiled the first National Strategy for Clinical Trials. CZECRIN also contributed to its development.

by Jana Čaloudová | 1. 7. 2026 | 2026, Uncategorized

On July 15, 2026, the Ministry of Health of the Czech Republic presented the first National Strategy for Clinical Trials of Human Medicinal Products...

CREATIC has obtained the first hospital exemption for a modern therapy medicinal product in the Czech Republic.

by Jana Čaloudová | 25. 6. 2026 | 2026

This is a momentous occasion for modern Czech medicine and for patients who find themselves in a situation where standard treatment options are...

Clinical Trials in the Czech Republic: An Investment in Patients, Medicine, and the Future of Healthcare

by Jana Čaloudová | 23. 6. 2026 | 2026, Uncategorized

There are currently 486 clinical trials underway in the Czech Republic, involving more than 2,300 research teams. In 2025 alone, these trials gave...

The CREATIC Summer Breakfast Presented the Latest Research Findings and New Options for Undiagnosed Patients

by Jana Čaloudová | 11. 6. 2026 | 2026

In June, the CREATIC Center of Excellence hosted another edition of its “CREATIC Breakfast,” a regular informal gathering that brings together...

CREATIC Annual Meeting 2026: Moving Forward Together into the Next Phase of the Center’s Development

by Jana Čaloudová | 1. 6. 2026 | 2026

The CREATIC consortium’s annual meeting took place in Copenhagen on May 27–29, 2026. The three-day program provided partners with an opportunity to...

Behind every new treatment is a clinical trial. And behind many of them is CZECRIN.

by Veronika Plachá | 3. 2. 2026 | 2025, Clinical trials and studies, Collaboration, DONET, News

Behind every drug that becomes part of modern medicine is a long and carefully controlled journey. Before a new treatment enters routine clinical...

EUPATI – A Path Toward Collaboration Among Patients, Researchers, Regulatory Experts, and Pharmaceutical Companies

by Markéta Salačová | 2. 2. 2026 | 2025, Collaboration, Education, News

What is EUPATI? The European Patients’ Academy for Therapeutic Innovation (EUPATI) is a unique pan-European educational initiative established as a...

A Turning Point in Modern Medicine: Psychedelics Enter Clinical Practice

by Markéta Salačová | 22. 1. 2026 | 2026, Clinical trials and studies, Collaboration, News

Starting on the 1st 1. As of 2026, psychedelic substances may be used for medical purposes in the Czech Republic.This step is the result of...

Happy New Year 2026

by Markéta Salačová | 3. 12. 2025 | 2026, News

As we enter the new year, we wish everyone involved in clinical research, above all, good health, stability, and favorable working conditions that...

EP ERA4Health 2025

by Markéta Salačová | 2. 10. 2025 | 2025, News

The call for proposals for randomized clinical trials is coming soon!Fostering a European Research Area for Health (ERA4Health): a partnership that...

« Older Entries

Behind every new treatment is a clinical trial. And behind many of them is CZECRIN.

by Veronika Plachá | 3 February, 2026 | 2025, Clinical trials and studies, Collaboration, DONET, News | 0 Comments

Behind every drug that becomes part of modern medicine is a long and carefully controlled journey. Before a new treatment enters routine clinical practice, it must be validated in a clinical trial, in an environment where science, clinical experience and patient...

EUPATI – A Path Toward Collaboration Among Patients, Researchers, Regulatory Experts, and Pharmaceutical Companies

by Markéta Salačová | 2 February, 2026 | 2025, Collaboration, Education, News | 0 Comments

What is EUPATI? The European Patients’ Academy for Therapeutic Innovation (EUPATI) is a unique pan-European educational initiative established as a partnership between the public and private sectors and other stakeholders. Its main goal is to provide patients and...

A Turning Point in Modern Medicine: Psychedelics Enter Clinical Practice

by Markéta Salačová | 22 January, 2026 | 2026, Clinical trials and studies, Collaboration, News | 0 Comments

Starting on the 1st 1. As of 2026, psychedelic substances may be used for medical purposes in the Czech Republic.This step is the result of long-term, systematic scientific and clinical work based on solid data, an emphasis on patient safety, and a responsible...

Happy New Year 2026

by Markéta Salačová | 3 December, 2025 | 2026, News | 0 Comments

As we enter the new year, we wish everyone involved in clinical research, above all, good health, stability, and favorable working conditions that improve patient care.Thank you for a year together filled with projects, the sharing of expertise, and the strengthening...

EP ERA4Health 2025

by Markéta Salačová | 2 October, 2025 | 2025, News | 0 Comments

The call for proposals for randomized clinical trials is coming soon!Fostering a European Research Area for Health (ERA4Health): a partnership that aims to establish flexible and effective coordination among research funding organizations in the European Research Area...

ICH GCP E6 (R3) Course

by Markéta Salačová | 20 August, 2025 | 2025, Collaboration, Education, News | 0 Comments

❓ Do you want to understand the principles of the new version of ICH GCP E6 (R3)?❓ Who has what roles and responsibilities in clinical research?❓ How do the rules reflect digitization, data processing, and new technologies?❓ What are the benefits of emphasizing...

How does treatment for gastrointestinal cancer affect the possibility of having children? Take part in an international questionnaire study

by Markéta Salačová | 22 April, 2025 | 2025, News | 0 Comments

Cancer treatment saves lives, but it can also have long-term adverse effects that are less talked about - for example, the impact on the ability to have children. Many patients with cancers of the digestive tract, including...

TOP 50 doctors in the Czech Republic according to Forbes 2025

by Markéta Salačová | 14 January, 2025 | 2025, News | 0 Comments

Our colleagues are once again ranked in the Forbes magazine! A few days ago, Forbes Czechia published its third ranking TOP 50 male and female doctors. Once again, the best doctors in the Czech Republic include colleagues who work closely with the large research...

How to overcome barriers in vaccine research?

by Veronika Plachá | 12 December, 2024 | 2024, News | 0 Comments

How to overcome barriers in vaccine research? 🌍 How to overcome barriers in vaccine research? 💉 Underrepresentation among participants in clinical trials testing vaccines remains a major challenge. This is particularly true for vulnerable and hard-to-reach...

Regina Demlová – new Chair of the Network Committee for ECRIN-ERIC

by Markéta Salačová | 12 December, 2024 | 2024, News | 0 Comments

Regina Demlová - new Chair of the Network Committee for ECRIN-ERIC 🎉 We have news from ECRIN-ERIC, CZECRIN and CREATIC! 🎉 We are proud to announce that Regina Demlova, Director of MUNI | CREATIC and Director of the National Research Infrastructure CZECRIN, has been...